Poly Medicure Ltd submits investor presentation reporting FY26 consolidated revenue of ₹1,875 cr and PAT of ₹321 cr
- FY26 operating EBITDA: ₹458 cr; EBITDA margin: 24.4%.
- Cash and cash equivalents stood at ₹839 cr as of 30 September 2026.
- Presentation accompanied unaudited results for the quarter ended 30 September 2026; it did not provide Q2 financial figures.
